Faers - Open Access .click

Results 151 to 160 of about 15,628 (311)

Real-world pharmacovigilance study on neonatal congenital anomalies associated with maternal drug exposure using the FDA Adverse Event Reporting System

Therapeutic Advances in Drug Safety
Background: Congenital anomalies represent a significant public health concern, with maternal drug exposure during pregnancy being a potential modifiable risk factor.
Jingping Zheng, Zhenpo Zhang, Lin Ma, Ling Su +3 more
doaj +1 more source

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)

Frontiers in Pharmacology
Aim and background: This study attempted to identify similarities and differences in adverse events (AEs) between human epidermal growth factor receptor 2 (HER2) inhibitors, especially those related to hemorrhagic events and nervous system disorders ...
Yiwen Bao +6 more
semanticscholar +1 more source

ANNUAL Anesthesiology/FAER SESSION [PDF]

Anesthesiology, 2008
openaire +1 more source

Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database [PDF]

Guisen Yin, Guiling Song, Shuyi Xue, Fen Liu +3 more
openalex +1 more source

Causes of drug-induced photosensitivity: an analysis using FDA adverse event reporting system database

Scientific Reports
The purpose of this study is to analyze FAERS data to identify cases of drug-induced photosensitivity (DIP), examine demographic patterns, determine the drug classes involved, and highlight emerging trends in these reactions.
Lele Ge, Xianghua Huang, Zhu Dong, Tao Zhong +3 more
doaj +1 more source

Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names [PDF]

, 2015

core +1 more source

Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study [PDF]